Year archive

Vaxil Bio Ltd. — 2021 filings

All 14 regulatory filings released by Vaxil Bio Ltd. (VXL) in 2021, sourced directly from the official regulator.

14 Filings

2021 Period

2021 filings (14)

Filing	Released	Lang
52-109FV2 - Certification of interim filings - CEO (E).pdf Regulatory Filings	2021-11-25	English
52-109FV2 - Certification of interim filings - CFO (E).pdf Regulatory Filings	2021-11-25	English
Interim MD&A - English.pdf Regulatory Filings	2021-11-25	English
Interim financial statements/report – English.pdf Regulatory Filings	2021-11-25	English
News release - English.pdf Regulatory Filings	2021-09-29	English
News release - English.pdf Regulatory Filings	2021-05-05	English
52-109FV1 - Certification of annual filings - CFO (E).pdf Regulatory Filings	2021-04-30	English
52-109FV1 - Certification of annual filings - CEO (E).pdf Regulatory Filings	2021-04-30	English
Annual MD&A - English.pdf Regulatory Filings	2021-04-30	English
Audited annual financial statements – English.pdf Regulatory Filings	2021-04-30	English
AB form 13-501F1 (class 1 and 3B reporting issuers - participation fee).pdf Regulatory Filings	2021-04-30	English
ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).pdf Regulatory Filings	2021-04-30	English
News release - English.pdf Regulatory Filings	2021-03-11	English
News release - English.pdf Regulatory Filings	2021-02-01	English